Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based studyResearch in context

• Autori principali: Pamela V. Martino-Adami (Autore), Madhurima Chatterjee (Autore), Luca Kleineidam (Autore), Siegfried Weyerer (Autore), Horst Bickel (Autore), Birgitt Wiese (Autore), Steffi G. Riedel-Heller (Autore), Martin Scherer (Autore), Kaj Blennow (Autore), Henrik Zetterberg (Autore), Michael Wagner (Autore), Anja Schneider (Autore), Alfredo Ramirez (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2024-10-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Summary: Background: Blood-based biomarkers offer a promising, less invasive, and more cost-effective alternative for Alzheimer's disease screening compared to cerebrospinal fluid or imaging biomarkers. However, they have been extensively studied only in memory clinic-based cohorts. We aimed to...